Search

Astellas Pharma Inc.
  • Top MenuTeam
  • Top MenuPortfolio
  • Top MenuContact
  • Top MenuNews

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  1. Home
  2. News

News

Important Notice

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.

 

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

Accept
Search
  • 2023
  • 2022
  • 2021
  • Previous
  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • Jun
  • Jul
  • Aug
  • Sep
  • Oct
  • Nov
  • Dec
Error

Feb 16, 2023

Global
Feb 16, 2023
Avilar Therapeutics Increases Financing to $75 Million to Advance Pipeline of Novel Extracellular Protein Degraders
Read More

Jan 19, 2023

Global
Jan 19, 2023
NeoPhore completes extension to Series B financing to further advance discovery pipeline
Read More

Dec 13, 2022

Global
Dec 13, 2022
Astellas and MBC BioLabs Announce 2022 Future Innovator Prize Awarded to Bespoke Biotherapeutics and Cellinfinity Bio
Read More

 

Contact

Astellas Venture Management LLC
2000 Sierra Point Pkwy, Suite 500,
Brisbane, CA 94005

 

footer logofooter solgan

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • COOKIES POLICY
  • LEGAL DISCLAIMER
  • CONTACT
© Copyright March 2023 Astellas Venture Management

Update cookie preferences